Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents
Public ClinicalTrials.gov record NCT02586688. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Sham-Controlled Trial Evaluating the Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety and efficacy of daily, active Neurostar® TMS (when compared with sham treatment) in adolescents meeting criteria for Major Depressive Disorder (MDD).
Study identification
- NCT ID
- NCT02586688
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 112 participants
Conditions and interventions
Conditions
Interventions
- Active NeuroStar® Transcranial Magnetic Stimulation (TMS) Device
- Sham NeuroStar® Transcranial Magnetic Stimulation (TMS) Device
Device
Eligibility (public fields only)
- Age range
- 12 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2015 (Type not available)
- Primary completion
- Jan 2018 (Actual)
- Completion
- Dec 2018 (Actual)
- Last update posted
- Jun 12, 2025
2015 – 2018
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dothan Behavioral Medicine | Dothan | Alabama | 36303 | — |
| UCLA | Los Angeles | California | 90024 | — |
| Stanford University | Palo Alto | California | 94305 | — |
| Rocky Mountain TMS | Grand Junction | Colorado | 81501 | — |
| Florida Clinical Practice Association, Inc. | Gainesville | Florida | 32606 | — |
| Anchor Neuroscience | Pensacola | Florida | 32502 | — |
| Beacon Medical Group | South Bend | Indiana | 46601 | — |
| Integrative Psychiatry | Louisville | Kentucky | 40222 | — |
| Sheppard Pratt Health System | Baltimore | Maryland | 21285 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | 45219 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02586688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02586688 live on ClinicalTrials.gov.